Inhibition of methionine adenosyltransferase by the polyamines.
The effect of the polyamines, putrescine, spermine, and spermidine, on the activity of extrahepatic methionine adenosyltransferase (MAT II) was studied. The polyamines inhibited MAT II activity at concentrations equal to or greater than 5 mm. Combinations of polyamines were more effective than individual polyamines in inhibiting MAT activity; maximum inhibition approached 80% with combinations of all three polyamines. S-Adenosylmethionine (AdoMet), Pi, and PPi, the products of the MAT reaction, are known to be synergistic inhibitors of the nonhepatic form of the enzyme. Combinations of polyamines plus Pi and/or PPi induced an additive inhibition of the enzyme. AdoMet plus polyamines also resulted in significant inhibition, but inhibition plateaued at about 80%, indicating the presence of a protective mechanism to maintain AdoMet synthesis. Extrahepatic MAT from human and rat tissues was inhibited by the polyamines, indicating that this phenomenon is not species specific. In addition, we examined the effect of polyamines on MAT activity in resting and activated human lymphocytes that were shown to differ in the relative expression of MAT II subunits. Although MAT from mitogen (phytohemagglutinin, PHA)- and superantigen (Staphylococcal enterotoxin B, SEB)-stimulated lymphocytes were similarly inhibited by 10 mM polyamines, at lower concentrations of polyamines (1-5 mM), MAT from SEB-stimulated cells appeared to be more susceptible to inhibition by the polyamines. Inasmuch as SEB is a more physiological stimulator of T cells than PHA, the data suggest a possible role of polyamines in regulating MAT activity.
Geller
A M
AM
Department of Biochemistry, The University of Tennessee, Memphis, Tennessee 38163, USA. ageller@physio1.utmem.edu
Legros
H L
HL
Wherry
K
K
Kotb
M Y
MY
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007908:Lens, Crystalline / Q000201:enzymology; D007938:Leukemia / Q000201:enzymology; D008213:Lymphocyte Activation; D008716:Methionine Adenosyltransferase / Q000037:antagonists & inhibitors*; D008934:Mitogens / Q000494:pharmacology; D010710:Phosphates / Q000494:pharmacology; D011073:Polyamines / Q000494:pharmacology*; D011700:Putrescine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000201:enzymology; D012436:S-Adenosylmethionine / Q000494:pharmacology; D013095:Spermidine / Q000494:pharmacology; D013096:Spermine / Q000494:pharmacology; D013601:T-Lymphocytes / Q000201:enzymology
D004791:Enzyme Inhibitors; D007527:Isoenzymes; D008934:Mitogens; D010710:Phosphates; D011073:Polyamines; D013096:Spermine; D012436:S-Adenosylmethionine; D008716:Methionine Adenosyltransferase; D013095:Spermidine; D011700:Putrescine